Nonsurgical Brow Lift

The frontalis muscle runs vertically along the forehead and is the only true elevator of the brow. Think of it as a single cable pulling upward; resisting it from below are three depressors. The corrugator supercilii ("the frown muscle") pulls the medial brow downward and inward; the procerus draws the nasal root and medial brow downward; and the orbital portion of the orbicularis oculi exerts a consistent downward pull on the outer brow tail.

In youth the balance holds the brow at or slightly above the supraorbital rim — the bony ledge of the eye socket — with the outer tail arching slightly higher in most women and sitting flatter in most men. Over time, soft tissue between skin and bone begins to lose volume, the brow's attachment points begin to weaken, and the depressor pull on the outer tail goes increasingly unopposed. The outer brow descends, the upper eyelid gains soft tissue it did not carry before, and the eye begins to convey fatigue when none is there.

Two structures contribute to the heavy upper-eye appearance and must be evaluated separately: brow position, and the amount of skin on the upper eyelid itself. They often coexist. Treating the brow does not reduce excess lid skin; treating excess lid skin does not reposition a low brow. The consultation is where that distinction is made, and the treatment plan follows from it. This is also why nonsurgical brow lifting is a distinct technique from routine forehead treatment — relaxing the frontalis without considering brow position can cause the brow to fall further.

Well-suited candidates. The approach works best for patients with mild lateral brow descent — a brow tail that has settled at or within a few millimeters of the supraorbital rim — who want a modest improvement and understand the role of ongoing maintenance. Patients who want to avoid surgery, defer it, or explore what nonsurgical treatment achieves before committing to a surgical plan are appropriate candidates for this approach.

Who will be disappointed. Patients expecting a result comparable to a surgical brow lift will not get it. A surgical procedure repositions the entire brow, anchors it, and maintains the correction for years. An injectable treatment repositions the outer tail by 1 to 3 millimeters, requires maintenance every 3 to 4 months, and cannot address significant structural ptosis.

Patients whose heavy upper-eye appearance comes primarily from excess skin on the upper eyelid — rather than from brow descent — will not see meaningful improvement from brow-lifting treatment. For those patients, blepharoplasty is the more direct answer. Patients with true brow ptosis — structural descent beyond what muscle relaxation can reach — are better served by surgery. We say this directly in consultation rather than offering repeated courses of injectables that will not reach the goal.

Common. Bruising and swelling at the injection sites are the most frequent side effects. Bruising is not preventable with certainty; it resolves within days to a week. Small welts or redness at the injection sites immediately after treatment resolve within minutes to hours.

Brow asymmetry. Pre-existing asymmetry is present in most faces and can become more apparent when one side responds differently. New asymmetry from unequal treatment effect is correctable at the two-week follow-up visit once the full effect has developed.

Over-correction and surprised appearance. Relaxing the depressors too aggressively, or spreading product into the lateral frontalis, can produce an abnormally arched or peaked brow. This resolves as the product wears off. Careful placement and conservative dosing reduce this risk.

Upper eyelid ptosis. The levator palpebrae superioris — the muscle that opens the upper eyelid — runs immediately beneath the orbital rim. If product migrates to this muscle, it can produce a drooping upper lid. This is uncommon when product is placed at appropriate concentrations and sites, and it resolves as the product wears off. Patients who experience it should contact the practice.

Brow or forehead heaviness. If the frontalis is partially affected by product spread from brow-depressor treatment, patients may notice the forehead feeling heavier or the brow sitting lower than baseline for a period. This resolves as the product wears off.

Filler-specific risks. When filler is placed in the temporal or periorbital region, the standard risks of filler treatment in a vascular area apply — bruising, swelling, nodule formation, and, very rarely, vascular compromise. These are discussed at consultation before filler is added to a treatment plan. See the dermal fillers page for a full discussion.

The mechanism is selective muscle relaxation. A neuromodulator — botulinum toxin type A, available as Botox, Dysport, or Xeomin, each described on the wrinkle relaxers page — blocks acetylcholine release at the nerve-muscle junction. The muscle cannot contract until it rebuilds those junctions, a process that takes months.

By targeting the lateral orbicularis oculi — the outer portion of the ring muscle surrounding the eye — we remove the primary downward vector on the outer brow tail. The frontalis, now less opposed, can hold the brow at a higher position with the same contractile effort. The lift concentrates at the lateral third of the brow; this is not a technique that reshapes the entire brow or replicates a younger anatomy.

Injecting the corrugator supercilii and procerus — the medial brow depressors — is often performed at the same visit to address glabellar lines and contribute to overall brow shape. The frontalis itself is treated conservatively, or not at all, in patients who want brow lifting; relaxing the forehead directly opposes the lift. In patients who want both a smoother forehead and a lifted brow, doses and placement require coordination.

What the studies show. Controlled series measuring brow position before and after lateral orbicularis injection have documented statistically significant elevation at the outer brow — 1 to 4.8 mm, depending on technique and patient selection. The lift is measurable and repeatable. For the right patient, a brow tail that sits a millimeter or two higher reads as less tired — and that is the honest description of the result.

Where the limits are. One to three millimeters is a small number. At a conversational distance, a 1 mm change in brow height is unlikely to be noticed by an observer who does not know it happened. The patient beginning with 2 to 3 mm of lateral descent may notice a genuine difference in photographs. The patient beginning with 7 to 10 mm of structural ptosis will achieve a result that measures within range but falls far short of what they hoped.

The practical upshot: this treatment suits patients who want a subtle, repeatable improvement in mild descent. It is not appropriate as a substitute for surgery when the degree of descent clearly exceeds what injectables can address. We draw that line plainly at consultation.

Consultation. Brow and upper eyelid position are assessed together, since the two structures contribute to the same appearance and must be distinguished. We take a standardized series of photographs in relaxed and animated positions, note the degree of brow descent and frontalis compensation, and discuss realistic expectations for the nonsurgical approach and, where relevant, what surgery would offer.

Treatment planning. Injection sites are selected based on the anatomy assessed at consultation. The forehead is treated conservatively, if at all — relaxing it directly opposes the lift. Placement is precise; a few millimeters in the wrong direction changes the result.

The injection. The skin is cleansed and a very fine needle is used at each site; topical numbing cream is available if wanted. The appointment takes a few minutes.

Results. The neuromodulator begins working over the first few days. Most patients notice changes at day 3 to 5; the full effect is established at 10 to 14 days. A brief follow-up appointment is offered at that point to assess the result and make any small adjustments. There is no required downtime; patients resume normal activities the same day.

Surgical brow lift. For patients where the degree of descent, the goals, or the expected durability of the result points clearly toward surgery, a surgical brow lift is the direct alternative. Surgical options include endoscopic, temporal, and — for the right hairline and degree of descent — coronal or hairline approaches. The correction is more substantial, affects the full brow, and lasts years. This practice performs surgical brow lifting at its surgical suite in the Syracuse office.

Blepharoplasty. When excess upper eyelid skin is the primary cause of hooding, upper eyelid surgery is the more direct answer. The two procedures are sometimes combined when both structures contribute; the consultation determines which takes priority.